Congress Acts to End PAMA Price Cutting Reign of Terror
After years of resistance, the lab industry’s hopes and prayers for relief from the flawed pricing scheme may soon be answered.
Already a member? Log in here
HHS Scrambles to Deal with Aftermath of Roe v. Wade Revocation
Now that the Supreme Court has revoked Roe v. Wade, HHS must rework policies, programs, and procedures related to reproductive rights.
Congressional Bill Offers Labs PAMA Pricing Relief
Legislation introduced last week would require the use of a more reliable representative sample to determine lab test reimbursement rates.
Bill to Regulate LDTs Advances, but Is No Slam Dunk for Final Passage
Now that the finishing touches have been put on LDT-related legislation, what is the likelihood that it will pass?
Already a member? Log in here
Laboratory Developed Test Regulatory Reform Moves Closer to Reality
Newly proposed legislation would establish a risk-based regulatory system for LDT regulation, though not everyone is happy with it.
Already a member? Log in here